There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vir Biotechnology (VIR – Research Report), ...
Analyst Michael Ulz of Morgan Stanley maintained a Hold rating on Alnylam Pharma (ALNY – Research Report), retaining the price target of ...